Faculty profile

Jean-Claude Forest

ResearcherUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.

Jean-Claude Forest

Researcher

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
13 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bdnf Birthweight Maternal Prenatal Stress Prematurity Stress Biomarker Chromosomal Aneuploidy Diagnostic Test Accuracy Review Genomic-Based Fetal Testing

Latest papers

Assessment of pregnant women's intention to use a mobile application-based decision aid for prenatal screening for trisomies 21, 18 and 13: A mixed-methods cross-sectional study.
Patient education and counseling · 2026
Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.
Journal of patient-reported outcomes · 2026
Differential expression of ADAM10 in fetal membranes during pregnancy and evaluation as an early blood biomarker for preterm birth.
Journal of reproductive immunology · 2026

All 44 publications

Latest funding

L'inversion de la pyramide des soins anténataux pour améliorer l'accès aux soins et la santé des mères et des enfants vivant en région éloignée (PROJET PYRAMIDE)
CIHR · 2024 · Co-investigator
$599,003
COVIGRO : Impact de la COVID-19 et du vaccin contre SARS-CoV-2 sur le développement du placenta et du foetus
CIHR · 2021 · Co-investigator
$268,186
Maternal serum Brain-Derived Neurotrophic Factor (BDNF): Study of a promising biomarker of maternal psychological stress during pregnancy
CIHR · 2021 · Principal investigator
$122,400

All 12 grants and awards

44 publications.

Assessment of pregnant women's intention to use a mobile application-based decision aid for prenatal screening for trisomies 21, 18 and 13: A mixed-methods cross-sectional study.

Ahouehome SAC, Bureau A, Rahimi SA, Gadio S, Julien Y, Assan OQ, Guay-Belanger S, Rousseau F, Forest JC, Langlois S, Ravitsky V, Archambault P, Légaré F

Patient education and counseling2026

DOI: 10.1016/j.pec.2026.109548 PMID: 41780090

Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.

Dubeau A, El Balqui M, Talbot D, Rousseau F, Langlois S, Chen W, Audibert F, Bujold E, Forest JC, Dofara SG, Légaré F

Journal of patient-reported outcomes2026

DOI: 10.1186/s41687-026-01020-5 PMID: 41793622

Differential expression of ADAM10 in fetal membranes during pregnancy and evaluation as an early blood biomarker for preterm birth.

Kahouadji S, Puravet A, Belville C, Giguère Y, Forest JC, Blanchon L, Durif J, Pereira B, Sapin V, Gallot D, Bouvier D

Journal of reproductive immunology2026

DOI: 10.1016/j.jri.2026.104853 PMID: 41643252

Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8 Weeks of Gestational Age.

Daryabari SS, Giroux S, Caron A, Forest JC, Langlois S, Bujold E, Rousseau F

Clinical genetics2026

DOI: 10.1111/cge.70020 PMID: 40616292

Real-life implementation of prenatal cell-free DNA screening with in vitro fetal enrichment virtually eliminates the need for redraws and improves performance: A cohort study.

Giroux S, Daryabari SS, Caron A, Jeukens J, Giguère Y, Forest JC, Audibert F, Bujold E, Langlois S, Rousseau F

Genetics in medicine open2025

DOI: 10.1016/j.gimo.2025.103458 PMID: 41210373

Reinfection With Cytomegalovirus During Pregnancy: A Prospective Cohort Study in Canada.

St-Georges J, Balegamire SJ, Larouche A, Boppana S, Renaud C, Mâsse B, Giguere Y, Forest JC, Lamarre V, Audibert F, Gantt S, Boucoiran I

Journal of medical virology2025

DOI: 10.1002/jmv.70261 PMID: 39992059

First-Trimester PlGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study.

Côté ML, Giguère Y, Forest JC, Audibert F, Johnson JA, Okun N, Guerby P, Ghesquiere L, Bujold E

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC2025

DOI: 10.1016/j.jogc.2024.102732 PMID: 39631521

Association Between Maternal Cytomegalovirus Seropositivity, Preterm Birth, and Preeclampsia in Two Cohorts From Quebec, Canada: A Mediation Analysis.

Balegamire SJ, Mâsse B, Audibert F, Lamarre V, Giguere Y, Forest JC, Boucoiran I

American journal of reproductive immunology (New York, N.Y. : 1989)2024

DOI: 10.1111/aji.13941 PMID: 39436114

Prospective Validation of First-Trimester Screening for Preterm Preeclampsia in Nulliparous Women (PREDICTION Study).

Guerby P, Audibert F, Johnson JA, Okun N, Giguère Y, Forest JC, Chaillet N, Mâsse B, Wright D, Ghesquiere L, Bujold E

Hypertension (Dallas, Tex. : 1979)2024

DOI: 10.1161/hypertensionaha.123.22584 PMID: 38708601

CX3CL1/Fractalkine as a biomarker for early pregnancy prediction of preterm premature rupture of membranes.

Kahouadji S, Giguère Y, Lambert S, Forest JC, Bernard N, Blanchon L, Marceau G, Durif J, Pereira B, Gallot D, Sapin V, Bouvier D

Clinical chemistry and laboratory medicine2024

DOI: 10.1515/cclm-2023-1202 PMID: 38278625

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Bdnf Dear Professor Forest, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Assessment of pregnant women's intention to use a mobile application-based decision aid for prenatal screening for trisomies 21, 18 and 13: A mixed-methods cross-sectional study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Maternal serum Brain-Derived Neurotrophic Factor (BDNF): Study of a promising biomarker of maternal psychological stress during pregnancy" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Jean-Claude Forest

Research

Latest papers

Latest funding

Assessment of pregnant women's intention to use a mobile application-based decision aid for prenatal screening for trisomies 21, 18 and 13: A mixed-methods cross-sectional study.

Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.

Differential expression of ADAM10 in fetal membranes during pregnancy and evaluation as an early blood biomarker for preterm birth.

Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8&#x2009;Weeks of Gestational Age.

Real-life implementation of prenatal cell-free DNA screening with in vitro fetal enrichment virtually eliminates the need for redraws and improves performance: A cohort study.

Reinfection With Cytomegalovirus During Pregnancy: A Prospective Cohort Study in Canada.

First-Trimester PlGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study.

Association Between Maternal Cytomegalovirus Seropositivity, Preterm Birth, and Preeclampsia in Two Cohorts From Quebec, Canada: A Mediation Analysis.

Prospective Validation of First-Trimester Screening for Preterm Preeclampsia in Nulliparous Women (PREDICTION Study).

CX3CL1/Fractalkine as a biomarker for early pregnancy prediction of preterm premature rupture of membranes.

Frequent collaborators

Emmanuel Bujold

Yves Giguere

Isabelle Boucoiran

Linda Dodds

Soren Gantt

Christian Renaud

Julian Little

Daniel Reinharz

Isabelle Marc

Sylvie Dodin

Audrey Durand

Kate Zinszer

Denis Talbot

Samira Abbasgholizadeh Rahimi

Sylvie Girard

Hope Weiler

Arnaud Droit

Guy Rouleau

Alexandre Bureau

Patrick Archambault

Mark Walker

Richard Kremer

Christy Woolcott

Vardit Ravitsky

Michel Lucas

Aly Karsan

Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8 Weeks of Gestational Age.